Evidence-Based Complementary and Alternative Medicine

Research Article

Validity of a Diagnostic Scale for Acupuncture: Application of the Item Response Theory to the Five Viscera Score

Table 4

Correlation in male and female of the Five Viscera Score and SF-36.
GenerationSubscaleWhole ( )Male ( )Female ( )
LiverHeartSpleenLungKidneyLiverHeartSpleenLungKidneyLiverHeartSpleenLungKidney
PF−0.20***−0.23***−0.28***−0.03 −0.28***−0.20**−0.21**−0.30***0.00 −0.32***−0.18 −0.26**−0.25*−0.07 −0.18
RP−0.11 −0.37***−0.30***−0.06 −0.31***−0.11 −0.39***−0.28***−0.11 −0.34***−0.06 −0.34***−0.35***0.03 −0.24*
BP−0.40***−0.35***−0.41***−0.21***−0.32***−0.38***−0.31***−0.42***−0.22**−0.30***−0.36***−0.38***−0.38***−0.19 −0.27**
Whole subjectsGH−0.36***−0.49***−0.44***−0.15*−0.39***−0.33***−0.46***−0.40***−0.22**−0.39***−0.45***−0.56***−0.53***−0.02 −0.39***
VT−0.33***−0.57***−0.59***−0.07 −0.56***−0.31***−0.53***−0.59***−0.09 −0.55***−0.34***−0.63***−0.61***−0.05 −0.54***
SF−0.17**−0.41***−0.37***−0.25***−0.45***−0.15 −0.36***−0.32***−0.26***−0.40***−0.18 −0.47***−0.45***−0.22*−0.50***
RE−0.11 −0.46***−0.36***−0.13*−0.42***−0.11 −0.46***−0.33***−0.17*−0.41***−0.07 −0.46***−0.40***−0.06 −0.41***
MH−0.33***−0.74***−0.46***−0.16**−0.54***−0.30***−0.76***−0.43***−0.14 −0.53***−0.33***−0.70***−0.49***−0.20 −0.53***
PF−0.23**−0.25***−0.27***0.04 −0.26***−0.25**−0.23*−0.27**0.10 −0.25**−0.19 −0.31*−0.26*−0.08 −0.25*
RP−0.10 −0.31***−0.26***−0.01 −0.28***−0.12 −0.29**−0.16 −0.04 −0.24*−0.04 −0.34**−0.42***0.03 −0.32*
BP−0.40***−0.38***−0.33***−0.25***−0.28***−0.39***−0.36***−0.34***−0.24*−0.25**−0.34**−0.38**−0.27*−0.27*−0.25*
Adolescents and young adults (18–29) GH−0.42***−0.50***−0.39***−0.16*−0.36***−0.38***−0.50***−0.38***−0.24*−0.37***−0.51***−0.50***−0.41***−0.03 −0.37**
VT−0.31***−0.54***−0.53***0.00 −0.53***−0.30**−0.49***−0.53***0.04 −0.51***−0.33**−0.61***−0.54***−0.07 −0.58***
SF−0.19*−0.42***−0.33***−0.22**−0.46***−0.18 −0.38***−0.30**−0.18 −0.37***−0.19 −0.47***−0.38**−0.27*−0.59***
RE−0.16*−0.43***−0.41***−0.08 −0.42***−0.13 −0.40***−0.30**−0.06 −0.37***−0.15 −0.46***−0.56***−0.08 −0.49***
MH−0.36***−0.72***−0.40***−0.11 −0.53***−0.32***−0.72***−0.36***−0.02 −0.49***−0.40***−0.73***−0.48***−0.24 −0.60***
PF−0.14 −0.21*−0.31**−0.17 −0.33***−0.11 −0.15 −0.34**−0.18 −0.42***−0.09 −0.25 −0.31 −0.19 −0.14
RP−0.11 −0.45***−0.35***−0.13 −0.37***−0.10 −0.50***−0.46***−0.18 −0.53***−0.05 −0.33 −0.24 0.00 −0.11
BP−0.40***−0.30**−0.55***−0.15 −0.39***−0.37**−0.20 −0.55***−0.17 −0.38**−0.38*−0.39*−0.58***−0.10 −0.34*
Adults (30+) GH−0.27**−0.46***−0.50***−0.14 −0.44***−0.25*−0.34**−0.41***−0.16 −0.44***−0.30 −0.68***−0.72***−0.07 −0.41*
VT−0.35***−0.64***−0.68***−0.15 −0.59***−0.33**−0.61***−0.69***−0.21 −0.66***−0.37*−0.71***−0.75***−0.07 −0.48**
SF−0.12 −0.36***−0.40***−0.27**−0.43***−0.10 −0.29*−0.33**−0.37**−0.48***−0.16 −0.47**−0.55***−0.06 −0.34*
RE−0.05 −0.50***−0.27**−0.19 −0.42***−0.08 −0.47***−0.35**−0.30*−0.51***0.10 −0.44**−0.07 0.06 −0.25
MH−0.27**−0.78***−0.56***−0.26**−0.56***−0.27*−0.81***−0.57***−0.32*−0.62***−0.17 −0.70***−0.55***−0.11 −0.39*
 *P < 0.05; **P < 0.01; ***P < 0.001 ( ; Spearman's rank correlation coefficient); PF: physical functioning; RP: role physical; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role emotional; MH: mental health. Whole ( ; male ; female ), adolescents/young adults ( ; male ; female ), and adults ( ; male ; female ).